Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital
Kidney Transplantation
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 84 Actual
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
Solid-organ transplant patients are at increased risk of infectious diseases. Among this population, infectious diseases may be life-threatening or lead to graft rejection. Their prevention is an important challenge. Despite specific national recommendations, vaccination is underutilized. That is why we propose a dedicated infectious diseases consultation during pre-kidney transplantation assessment.
Read the full description
The main objective of this study is to impove vaccine coverage before kidney transplantation.
Enrollment was based on the waiting list for a kidney transplant. Patients newly listed are invited to participate by the transplant team (nephrology department) ; for those that are already registered, a notification letter is sent to their home.
All patients included must :
- complete a health questionnaire
- take a blood test at day 0 : viral, bacterial and parasitic serologies, QuantiFERON-TB
- take a chest X-ray and dental panoramic Patients randomized in interventional group will be seen in specific infectious diseases consultation at Clermont Ferrand Hospital. A letter of recommendations is sent to nephrologist for patients randomized in group control.
The primary study endpoint (immunization coverage) is evaluated at 6 months.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- Patient over 18
- On the waiting list for kidney transplantation at Clermont-Ferrand
- Free and informed consent
- Affiliation to a social security system
Exclusion Criteria:
- Patient under 18
- Protected adults (individuals under guardianship by court order
- Pregnant and nursing women
- Prior graft (solid organs or hematopoietic stem cells)
- Absence of consent
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- No masking
Stronger pre-transplant check-up
routine patient management + specific infectious diseases consultation
Other: Specific infectious diseases consultation
Standard pre-transplant check-up
routine patient management + letter sent to nephrologist
Specific infectious diseases consultation OTHER
Specific infectious diseases consultation at Clermont Ferrand Hospital with a specialist doctor :
- Update vaccinations
- Advice to travelers
- Diagnostic and treatment of latent tuberculosis infection
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Vaccination coverage
Time frame: Month 6
The percentage of fully immunized patients according to the Recommendations of High Council for public Health
Secondary measures
Infectious complications
Time frame: within the 6 months of the transplantation
Infectious diseases which require special management (hospitalization, anti-infective treatments)
Mortality
Time frame: Month 6
Mortality after kidney transplantation
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
CHU de Clermont-FerrandClermont-Ferrand, FranceStatus unknown
Study team and timeline
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Study start
- Sep 16, 2020 Actual
- Primary completion
- Nov 30, 2021 Actual
- Study completion
- Nov 30, 2021 Actual
- First posted
- Mar 10, 2021 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
No central contact is listed. Check the locations and the official record.
Official study title
Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026